Filing Details

Accession Number:
0001144204-14-060377
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-09 17:03:17
Reporting Period:
2014-10-07
Filing Date:
2014-10-09
Accepted Time:
2014-10-09 16:03:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434868 Esperion Therapeutics Inc. ESPR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1253886 G Patrick Enright C/O Longitude Capital Partners, Llc
800 El Camino Real, Suite 220
Menlo Park CA 94025
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-10-07 11,692 $30.04 1,884,693 No 4 S Indirect By LVP
Common Stock Disposition 2014-10-07 235 $30.04 37,776 No 4 S Indirect By LCA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By LVP
No 4 S Indirect By LCA
Footnotes
  1. Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $30.00 to $30.30. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  2. Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $30.00 to $30.30. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  3. Mr. Enright is a managing member of Longitude Capital Partners, LLC ("Longitude Capital"). Longitude Capital, as general partner of each of Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Associates, L.P. ("LCA"), has the power to vote and dispose of securities held by each of them and may be deemed to beneficially own the shares held by LVP and LCA. Mr. Enright disclaims beneficial ownership of the shares held by LVP and LCA, except to the extent of his pecuniary interest therein.